← Back
$APLS All transactions

Apellis Pharmaceuticals, Inc.

A

$ Value

$0

Shares

58,140

Price

$0

Filed

Jan 30

Insider

Name

Sullivan Timothy Eugene

Title

Chief Financial Officer

CIK

0001707000

Roles

Officer

Transaction Details

Transaction Date

2026-01-28

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

152,041

Footnotes

This represents a Restricted Stock Unit award granted on January 28, 2026 that vest 25% annually over four years from grant date subject to continued service. | The securities are held by The Timothy E Sullivan Irrevocable Trust of 2023. Patrick O. Collins is the trustee of The Timothy E Sullivan Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The Timothy E Sullivan Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.

Filing Info

Accession No.

0001492422-26-000073

Form Type

4

Issuer CIK

0001492422

Sullivan Timothy Eugene's History

Date Ticker Type Value
2026-04-17 APLS G $0
2026-04-17 APLS G $0
2026-01-28 APLS A $0
2026-01-22 APLS $224K
2026-01-20 APLS $57K
2026-01-13 APLS $86K
2025-10-21 APLS M $100K
2025-10-21 APLS $280K
2025-10-21 APLS M $0
2025-09-08 APLS M $150K

Other Insiders at APLS (90d)

Insider Bought Sold Last
Dolsten Mikael 2026-02-27
Watson David O.
General Counsel
2026-01-28
Deschatelets Pascal
Chief Scientific Officer
2026-01-28
Francois Cedric
Chief Executive Officer
2026-03-11
Sullivan Timothy Eugene
Chief Financial Officer
2026-04-17
O'Brien Stephanie Monaghan 2026-04-06
Nicholson Nur
Chief Technical Officer
2026-01-28
Chopas James George
VP/Chief Accounting Officer
2026-01-28
DeLong Mark Jeffrey
Chief Business & Strat Officer
$8K 2026-02-11
Boucher Kelley
Chief People Officer
2026-01-28
MELTZER LESLIE
Chief Research and Development
2026-01-28